Joint DIA/MEB “Excellence in Pharmacovigilance” Module 4: Risk Management

Module 4 focus on risk minimisation measures from both regulatory and industry perspectives. It also covers epidemiological methods used in Pharmacovigilance, as well as risk management plans.

Continuing Education

The Swiss Association of Pharmaceutical Professionals (SwAPP) and the Swiss Society for Pharmaceutical Medicine (SGPM) have accredited this training course with 8 credits.
Special rates available for SwAPP and SGPM members.

Name	Credit Type	Max Credits	CEU
"Excellence in PV" Module 4, 22-23 Nov 2021, 08:30-14:00 CET, Virtual Event	Credit TypeSWAPP/SGPM	Max Credits8.00	CEU0.000

Statement of Credit:

All DIA training courses and meetings are accredited by the Swiss Association of Pharmaceutical Professionals (SwAPP) Commission for Professional Development (CPD) and Swiss Society of Pharmaceutical Medicine (SGPM).

Joint DIA/MEB “Excellence in Pharmacovigilance” Module 4: Risk Management

Continuing Education

Statement of Credit:

获得信息并保持参与